CROI 2018

BOSTON — Improved treatment, reduction in long-term complications, and the elimination of disparities in HIV prevention and outcomes will be in the spotlight at the upcoming Conference on Retroviruses and Opportunistic Infections (CROI) 2018.

Although there are unlikely to be any massive data presentations at the meeting, the combined power of numerous smaller trials is expected to make a difference for patients, said Judith Currier, MD, from the University of California, Los Angeles, who is chair of the conference.

“We are really chipping away at things here,” Currier told Medscape Medical News. “I don’t think you’ll see any major game changers at this conference, but you will see improvements in treatment, reductions in long-term complications, an edging toward understanding what it will take for a cure, and improvements in the treatment and prevention of TB.”

Vevazz Slim Line